A phase 1 dose escalation study of PRS-343, a HER2/4-1bb bispecific molecule, in patients with HER2-positive malignancies Meeting Abstract
| Authors: | Piha-Paul, S.; Bendell, J.; Tolcher, A.; Hurvitz, S.; Patnaik, A.; Shroff, R.; Pohlmann, P.; Zettl, M.; Hahn, N.; Krishnamurthy, A.; Duerr, M.; Mei, J.; Aviano, K.; Yusuf, R.; Matis, L.; Olwill, S.; Bruns, I.; Ku, G. |
| Abstract Title: | A phase 1 dose escalation study of PRS-343, a HER2/4-1bb bispecific molecule, in patients with HER2-positive malignancies |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-04-01 |
| Start Page: | A1 |
| End Page: | A2 |
| Language: | English |
| ACCESSION: | WOS:000540356400003 |
| DOI: | 10.1136/lba2019.2 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O82 -- Source: Wos |
